Intelligence Ventures

Intelligence Ventures is a venture capital firm strategically focused on the intersection of artificial intelligence and healthcare. The firm primarily invests in pre-seed and seed-stage companies based in the U.S. and Canada. Their investment criteria target businesses that integrate AI as a core component of their technology across four key verticals: Biotech/Pharma Tools (excluding drug development, focusing on enabling technologies), Medical Devices (with a clear path to accelerated regulatory approval), Diagnostics (prioritizing rapid, scalable, and cost-effective solutions), and Healthcare SaaS (data-driven platforms with clear market adoption).

Founded in 2023, Intelligence Ventures aims to nurture innovative startups and foster the next generation of industry leaders in AI-driven healthcare. The firm's investment process is designed to be efficient, backing founders with initial checks ranging from $25,000 to $50,000 to help them advance to their next developmental stage. They also engage LP Executive Committee investors in their due diligence process, who offer strategic support to founders.

The firm is actively deploying capital into promising ventures. Their portfolio includes companies developing AI-powered blood tests for detecting and monitoring liver disease with enhanced speed and accuracy, AI-driven electrocardiogram (ECG) analysis for rapid and precise detection of cardiac conditions, and AI-powered computer vision for contactless monitoring of vital signs and patient deterioration. These investments reflect their commitment to leveraging AI to drive reduced costs, improve patient outcomes, and enhance returns through innovative healthcare solutions.

Intelligence Ventures also offers opportunities for accredited investors to become limited partners in their 506(c) fund, providing a pathway to invest in the rapidly evolving AI healthcare ecosystem. The firm emphasizes a professional and personalized experience, offering support to their portfolio companies and investors.